Cyclization of Peptides through a Urea Bond: Application to the Arg-Gly-Asp Tripeptide

被引:6
作者
Schmidt, Julien [1 ]
Garambois, Veronique [1 ]
Rocheblave, Luc [2 ]
Martinez, Jean [2 ]
Pelegrin, Andre [1 ]
Cavelier, Florine [2 ]
Vives, Eric [1 ]
机构
[1] Univ Montpellier 1, INSERM, U896, IRCM,CRLC Val Aurelle Paul Lamarque, F-34298 Montpellier, France
[2] Univ Montpellier 2, CNRS UM1 UM2, Inst Biomol Max Mousseron, F-34095 Montpellier, France
关键词
angiogenesis; integrin; peptides; RGD; urea; IMPROVING TUMOR UPTAKE; CYCLIC RGD PEPTIDES; PHASE-I; INTEGRIN ALPHA(V)BETA(3); ALPHA-V-BETA-3; INTEGRIN; CILENGITIDE EMD-121974; STRUCTURAL BASIS; BINDING SITE; ARGININE; EXPRESSION;
D O I
10.1002/cbic.201000062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various synthetic cyclopeptides bind different cellular proteins with high affinity and specificity. In this study, we designed a new series of cyclic tetrapeptides containing the RGD sequence, a ligand for the alpha(v)beta(3) integrin receptor, in which the ring closure was performed through a urea bond between the a-amino group of the peptide and either the alpha- or the epsilon-amino group of an additional lysine. Interestingly, we showed that the urea-closed peptide had a higher affinity for alpha(v)beta(3) receptor than a reference pentacyclopeptide. Moreover, the synthetic strategy allows coupling of the resulting cyclic tetrapeptide through the carboxylic acid moiety of its lysine residue to fluorescent molecules or drugs. In addition, this strategy could be easily adapted for the cyclization of any other peptides.
引用
收藏
页码:1083 / 1092
页数:10
相关论文
共 41 条
  • [41] Discovery of subnanomolar arginine-glycine-aspartate-based αvβ3/αvβ5 integrin binders embedding 4-aminoproline residues
    Zanardi, Franca
    Burreddu, Paola
    Rassu, Gloria
    Auzzas, Luciana
    Battistini, Lucia
    Curti, Claudio
    Sartori, Andrea
    Nicastro, Giuseppe
    Menchi, Gloria
    Cini, Nicoletta
    Bottonocetti, Anna
    Raspanti, Silvia
    Casiraghi, Giovanni
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1771 - 1782